Tim Edwards, BIA Chairman, said: “I would like to welcome our new Board member and congratulate those that have been re-elected. They will continue to bring broad perspectives and expertise to complement the already considerable talents of the BIA Board. I believe there is a real opportunity to establish the BIA at the centre of the global life sciences industry, and look forward to working with the new and existing Board members towards this goal.
“I also extend my thanks to those Board members who will stand down at the end of the year for the time and effort which they have contributed to supporting and improving the UK bioscience environment.”
For further information, please contact Joseph Wildy, Director of Public Affairs and Policy, 020 7565 7195; jwildy@bioindustry.org. Notes to editors Dominique Kleyn is CEO of London Genetics Ltd
Clive Dix is Chairman of Crescendo Biologics
Andrew Heath is a Non-Executive Director at Morvus Technology Ltd
Alan Marchington is a partner at Apposite Capital LLP
BioIndustry Association
Established in 1989, the BIA (BioIndustry Association) exists to encourage and promote a financially sound and thriving bioscience sector within the UK economy and concentrates its efforts on emerging enterprise and the related interests of companies with whom such enterprise trades.
With over 250 members, the BIA supports a wide range of sectors, majoring on the human health benefits of the technology and represents the interests of these innovative companies to a broad section of stakeholders from patient groups to politicians, advancing its members interests both within the UK and internationally to create a healthy UK bioscience sector which benefits society. For further information, please go to: www.bioindustry.org
Daniel Bridge Policy Executive Tel +44 (0) 207 565 7144 Fax +44 (0) 207 565 7191 BioIndustry Association (BIA) 14/15 Belgrave Square London SW1X 8PS dbridge@bioindustry.org www.bioindustry.org
